Medicinal Cannabis Markets: Neurotech shares jumped more than 30% after the FDA granted Investigational New Drug status for its medicinal cannabis program targeting childhood autism, clearing the way for a phase III “Beyond Harmony” trial in the U.S. Legal & Policy: An Ohio federal judge ordered state officials to stop enforcing a hemp-to-marijuana reclassification law, but only for the products sold by the companies that challenged it. Regulatory & Retail Operations: Nunavut’s cannabis rules are still slowing store moves—an Iqaluit retailer must pass final approvals before reopening across the street. Industry Business: A chain of Catalyst-branded dispensaries agreed to a $300K settlement to resolve worker pay and break-related claims. Enforcement & Compliance: Pennsylvania’s new $50.8B budget passed without resolving major cannabis policy fights, including recreational legalization. Hemp/Compliance Litigation: Urb Cannabis urged the 7th Circuit to keep a dismissal intact in a hemp seller dispute tied to a raid. THC Products: Local breweries are bracing for a potential national THC beverage ban that could hit sales starting this fall. Workplace Safety: Manitoba’s workplace violence report highlights rising injuries across public-sector roles, underscoring the broader risk environment for workers.